Skip to main content
SpringerLink
Log in

Un commento a Boyers et al.: “Eltrombopag per il trattamento della porpora trombocitopenica immune o idiopatica cronica: valutazione di tecnologia singola presso il NICE”

  • Lettera
  • Published:
PharmacoEconomics Italian Research Articles

An Erratum to this article was published on 05 March 2014

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Boyers D, Jia X, Jenkinson D, Mowatt G. Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura—a NICE single technology appraisal. PharmacoEconomics. 2012;30(6):483–95.

    Article  PubMed  Google Scholar 

  2. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial. Lancet. 2008;371(9610):395–403.

    Article  CAS  PubMed  Google Scholar 

  3. Cheng G, Saleh MN, Marcher C, Vasey S, Mayer B, Aivado M, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet. 2011;377:393–402.

    Article  CAS  PubMed  Google Scholar 

  4. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Ringraziamenti

Tutti gli autori sono dipendenti di GlaxoSmithKline, il produttore di eltrombopag.

Author information

Authors and Affiliations

  1. GlaxoSmithKline Ltd, 1-3 Iron Bridge Road, Stockley Park West, Uxbridge, UB11 1BT, UK

    Rachel Allen, Andres Brainsky, Kelly Grotzinger & Tito Roccia

Authors
  1. Rachel Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andres Brainsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kelly Grotzinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tito Roccia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rachel Allen.

Additional information

Comment to DOI 10.1007/s40276-013-0013-3.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allen, R., Brainsky, A., Grotzinger, K. et al. Un commento a Boyers et al.: “Eltrombopag per il trattamento della porpora trombocitopenica immune o idiopatica cronica: valutazione di tecnologia singola presso il NICE”. PharmacoEcon Ital Res Artic 15, 153–155 (2013). https://doi.org/10.1007/s40276-013-0014-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40276-013-0014-2

Search

Navigation